1993
DOI: 10.1099/00221287-139-6-1353
|View full text |Cite
|
Sign up to set email alerts
|

Partial purification and properties of carminomycin 4-O-methyltransferase from Streptomyces sp. strain C5

Abstract: A methyltransferase that acts on carminomycin and 13-dihydrocarminornycin, and that is postulated to be the terminal enzyme in the daunomycin biosynthesis pathway, was purified to near-homogeneity from the daunomycinand baumycin-producing Streptomyces sp. strain C5. The enzyme was obtained in approximately 5 % yield with a purification of 114-fold in specific activity over the sample precipitated with 30-50 % ammonium sulphate. Polyacrylamide gel electrophoresis under denaturing conditions indicated a subunit … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
24
0

Year Published

1995
1995
2012
2012

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 15 publications
0
24
0
Order By: Relevance
“…The only previously proven reactions within this pathway were the 4-O-methylation of carminomycin and 13-dihydrocarminomycin to daunorubicin and 13-dihydrodaunorubicin, respectively (8,9,15,30,41), and the DoxA-catalyzed oxidation of daunorubicin to doxorubicin (14). The catalysts for all of the other reactions were either speculated, based on indirect evidence, or unknown.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The only previously proven reactions within this pathway were the 4-O-methylation of carminomycin and 13-dihydrocarminomycin to daunorubicin and 13-dihydrodaunorubicin, respectively (8,9,15,30,41), and the DoxA-catalyzed oxidation of daunorubicin to doxorubicin (14). The catalysts for all of the other reactions were either speculated, based on indirect evidence, or unknown.…”
Section: Resultsmentioning
confidence: 99%
“…The genes encoding carminomycin 4-O-methyltransferase have been isolated and sequenced from both Streptomyces sp. strain C5 (15) and S. peucetius ATCC 29050 (31), and the enzyme has been purified from both organisms (9,31,41). Cultures of S. lividans TK24(pANT502), containing only dauK (15) in the pANT849 expression vector (12,14), converted rhodomycin D to 4-O-methylrhodomycin D (52) (Table 2; Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Sinefungin was found to inhibit methyltransferases involved in the biosynthesis of secondary metabolites, causing the accumulation of demethylated antibiotics, as seen for avermectins (Schulman et al, 1985(Schulman et al, , 1987, citreamicin (Pearce et al, 1991), tylosin , pradimicins (Kakinuma et al, 1993;Saitoh et al, 1995) and staurosporine (Yang et al, 1999). S-Adenosyl-L-homocysteine, which is the common nucleoside reaction product, is often also employed to inhibit S-adenosyl-L-methionine-dependent methyltransferases in antibiotic biosynthesis (Bauer et al, 1988;Connors & Strohl, 1993;Kreuzman et al, 1988;Shafiee et al, 1994). Other methylation inhibitors are aminopterin (4-aminofolate), amethopterin (10-methylaminofolate), D-methionine and DL-ethionine.…”
Section: Introductionmentioning
confidence: 99%
“…Methionine, via its activated form, S-adenosyl-L-methionine, is considered as the general source of methyl groups in secondary metabolism (Roth et al, 1996). O-, Nand C-methyltransferases that use S-adenosyl-L-methionine as methyl donor are ubiquitous in the biosynthesis of secondary metabolites such as staurosporine (Yang et al, 1999), citreamicin (Pearce et al, 1991), avermectins (Schulman et al, 1986), erythromycin (Haydock et al, 1991), avilamycin (Weitnauer et al, 2002), daunomycin (Connors & Strohl, 1993), FK-506 (Shafiee et al, 1994), tylosin Seno & Baltz, 1981) and A10255 , the latter being a thiopeptide antibiotic belonging to the same class as GE2270. Much less is known about different methyltransferases involved in the biosynthesis of other antibiotics such as fortimicin, bialaphos and fosfomycin that seem to utilize methylcobalamin as a direct methyl donor Kuzuyama et al, 1992Kuzuyama et al, , 1995 and not as a prosthetic group.…”
Section: Introductionmentioning
confidence: 99%